# FDA 483 - SSG Ventures - September 30, 2021

Source: https://www.globalkeysolutions.net/records/483/ssg-ventures/614eb127-d2c4-4118-9369-6a21da1b6c44

> FDA 483 for SSG Ventures on September 30, 2021. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: SSG Ventures
- Inspection Date: 2021-09-30
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - East I
- Summary: SSG Ventures, a drug manufacturer in Carle Place, NY, was cited for significant deficiencies across its quality system. The inspection revealed a pervasive lack of written procedures, process validations, finished product testing, and adequate record-keeping, indicating a fundamental failure to adhere to cGMP requirements. These issues suggest a high risk to drug product quality, identity, strength, and purity.

## Related Officers

- [Tanya R. Syffrard](https://www.globalkeysolutions.net/people/tanya-r-syffrard/a78a42b3-6cef-46d9-9698-ec6082956477)
- [issuing_officer](https://www.globalkeysolutions.net/people/gam-s-zamil/75bc04d4-6013-43b5-8200-8b513c814a7c)

Company: https://www.globalkeysolutions.net/companies/ssg-ventures/a6408548-5f7b-411f-80e0-7bbe604b157b

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-east-i/a807f00e-d780-40b8-b233-1eb92ece8961